Lupus activation with cerebritis following pegylated interferon in a hemodialysis patient

被引:2
作者
Agarwal, Sanjay Kumar [1 ]
Lal, Charanjeet [1 ]
Zaidi, Sabahat Husain [1 ]
机构
[1] All India Inst Med Sci, Dept Nephrol, New Delhi 110029, India
关键词
STAGE RENAL-DISEASE; C VIRUS-INFECTION; HEPATITIS-C; DIALYSIS PATIENTS; ALPHA THERAPY; ERYTHEMATOSUS;
D O I
10.1038/nrneph.2009.137
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Background. a 20-year-old female patient with chronic hepatitis c virus infection and end-stage renal disease due to systemic lupus erythematosus was admitted to hospital with fever, pain in the abdomen, seizures and an alteration of consciousness. the patient was on maintenance dialysis and was receiving pegylated interferon monotherapy for her chronic hepatitis c virus infection. Investigations. Physical examination, laboratory tests including complete blood count and measurement of serum electrolyte levels, CT scans of the head and abdomen, MRI of the brain, microscopic examination of the cerebrospinal fluid, chest X-ray, echocardiography and measurement of C3 complement and anti-double-stranded DNA antibody levels. Diagnosis. activation of systemic lupus erythematosus with cerebritis following pegylated interferon therapy. Management. Intravenous fluid, intermittent oxygen, intravenous diphenylhydantoin, intravenous pulse methylprednisolone 500 mg for 3 days followed by 40 mg per day of oral prednisolone, and temporary withdrawal of pegylated interferon.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 18 条
[1]
The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection [J].
Akhan, S. C. ;
Kalender, B. ;
Ruzgar, M. .
INFECTION, 2008, 36 (04) :341-344
[2]
SEIZURES IN DIALYSIS PATIENTS TREATED WITH RECOMBINANT ERYTHROPOIETIN - REVIEW OF THE LITERATURE AND GUIDELINES FOR PREVENTION [J].
BECCARI, M .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (01) :5-13
[3]
SYSTEMIC LUPUS-ERYTHEMATOSUS IN PATIENTS WITH END-STAGE RENAL-DISEASE - LONG-TERM FOLLOW-UP ON THE PROGNOSIS OF PATIENTS AND THE EVOLUTION OF LUPUS ACTIVITY [J].
CHEIGH, JS ;
KIM, H ;
STENZEL, KH ;
TAPIA, L ;
SULLIVAN, JF ;
STUBENBORD, W ;
RIGGIO, RR ;
RUBIN, AL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (03) :189-195
[4]
Nonconvulsive status epilepticus in peritoneal dialysis patients [J].
Chow, KM ;
Wang, AYM ;
Hui, ACF ;
Wong, TYH ;
Szeto, CC ;
Li, PKT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (02) :400-405
[5]
GLADMAN DD, 1997, PRIMER RHEUMATIC DIS, P251
[6]
Interferon-induced lupus nephritis in a patient with chronic myeloid leukemia [J].
Goyal, HK ;
Wadhwa, J ;
Arora, B ;
Dawar, R ;
Agarwal, SK ;
Singh, D .
LEUKEMIA & LYMPHOMA, 2005, 46 (03) :481-482
[7]
Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C [J].
Ho, Vincent ;
Mclean, Anna ;
Terry, Shaughan .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (03) :166-168
[8]
HISTOLOGICAL GRADING AND STAGING OF CHRONIC HEPATITIS [J].
ISHAK, K ;
BAPTISTA, A ;
BIANCHI, L ;
CALLEA, F ;
DEGROOTE, J ;
GUDAT, F ;
DENK, H ;
DESMET, V ;
KORB, G ;
MACSWEEN, RNM ;
PHILLIPS, MJ ;
PORTMANN, BG ;
POULSEN, H ;
SCHEUER, PJ ;
SCHMID, M ;
THALER, H .
JOURNAL OF HEPATOLOGY, 1995, 22 (06) :696-699
[9]
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C [J].
Niewold, TB ;
Swedler, WI .
CLINICAL RHEUMATOLOGY, 2005, 24 (02) :178-181
[10]
Analysis of lupus activity in end-stage renal disease treated by hemodialysis [J].
Okano, K ;
Yumura, W ;
Nita, K ;
Uchida, K ;
Ohnuki, T ;
Kawashima, A ;
Nihei, H .
INTERNAL MEDICINE, 2001, 40 (07) :598-602